For investors
Own models. Own programs.One platform.
Epitorix designs radiopharmaceuticals with its own models, offers the products built on them, and runs its own programs.
4 programs
generated and validated in 2 months · expanding
program-level data · reveal soon
The company
Epitorix builds its own models, the products on them, and the drug programs that put both to the test.
Epitorix is an AI company for radiopharmaceutical discovery, development and de-risking. Its own models design peptide, antibody, nanobody and mini-protein candidates, and the same models predict what would fail them — off-target binding, biodistribution, organ and cell-type risk, PK and PD — before a trial does.
Our mission
To make the highest-stakes decisions in radiopharmaceutical development earlier, so the right candidates reach patients sooner.
Our vision
Drug development run as engineering: the reasons a candidate would fail, predicted before a trial rather than discovered in one.
The proof so far
Predicted before the clinic.
up to93%
Translational de-risking
accuracy detecting reported liabilities, retrospective analyses
100%
Experimental hit rate
hit rate at 500 nM affinity · 86% at 100 nM · experimentally validated designs, internal data
0.84
Affinity ranking
Pearson R, peptide pKd, internal benchmark
up to65×
faster from target to candidate
4–6 weeks versus 3–5 years, to a candidate ready for preclinical testing
up to100×
lower cost from target to candidate
up to $100K versus $5–10M, to a candidate ready for preclinical testing
Figures from retrospective analyses and internal benchmarks; a preprint describing the evaluation is forthcoming.
Programs
Four AI-designed radiopharmaceutical programs.
4 programs
generated and validated in 2 months · expanding
program-level data · reveal soon
Four AI-designed radiopharmaceutical programs are being tested in vivo. Program-level data will be published here.
Epitorix's pipeline programs are investigational and preclinical. No Epitorix product has been approved by the FDA, the EMA or any other regulator, and no clinical safety or efficacy has been established.
Assessment
“EPiQ™ compresses months of complex, PhD-level research into mere hours.”
Diligence
The methods, and what we have not measured yet.
Pipeline data and methods, available under NDA on request.
This page describes research programs that are investigational and preclinical. Statements about future work are forward-looking, depend on results not yet obtained, and may not be realised.
Contact
Start a conversation.
Tell us what you would like to see, and we will arrange it.
Laboratory bench · liquid handler and assay plates